BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 16550339)

  • 1. Joint inflammation and cytokine inhibition in rheumatoid arthritis.
    Christodoulou C; Choy EH
    Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF alpha as a therapeutic target in rheumatoid arthritis.
    Feldmann M; Brennan FM; Elliott M; Katsikis P; Maini RN
    Circ Shock; 1994 Aug; 43(4):179-84. PubMed ID: 7895323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokinin panel in rheumatoid arthritis and correlation with histological patterns of synovitis -- active type of disease.
    Avrămescu C; Vere CC; Mărgăritescu C; Turculeanu A; Bălăşoiu M; Rogoz S
    Rom J Morphol Embryol; 2005; 46(2):87-92. PubMed ID: 16286991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAPKs and their relevance to arthritis and inflammation.
    Thalhamer T; McGrath MA; Harnett MM
    Rheumatology (Oxford); 2008 Apr; 47(4):409-14. PubMed ID: 18187523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological agents in rheumatoid arthritis.
    Shankar S; Handa R
    J Postgrad Med; 2004; 50(4):293-9. PubMed ID: 15623977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with inhibition of interleukin-6.
    Choy E
    Rheum Dis Clin North Am; 2004 May; 30(2):405-15, viii. PubMed ID: 15172049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update in rheumatoid arthritis therapy.
    Kim-Howard XR; Staudt L; James JA
    J Okla State Med Assoc; 2005 Feb; 98(2):53-62. PubMed ID: 15789642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Etanercept (Enbrel)--our experiences].
    Morović-Vergles J; Martinović-Kaliterna D
    Reumatizam; 2007; 54(2):69-70. PubMed ID: 18351144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cytokines in the pathogenesis of rheumatoid arthritis.
    Feldmann M; Maini RN
    Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():3-7. PubMed ID: 10646481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials on biologics in rheumatoid arthritis.
    Sander O; Rau R
    Int J Clin Pharmacol Ther; 1998 Nov; 36(11):621-4. PubMed ID: 9849754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological therapies for rheumatoid arthritis.
    Edwards CJ
    Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Present and future therapeutic strategies in rheumatoid arthritis].
    Schacht E
    Z Rheumatol; 1993; 52(6):365-82. PubMed ID: 8147131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of TNF-alpha and cytokines in the physiopathology of rheumatoid arthritis. Therapeutic perspectives].
    Meyer O
    Bull Acad Natl Med; 2003; 187(5):935-54; discussion 954-5. PubMed ID: 14979058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
    Mathsson L; Lampa J; Mullazehi M; Rönnelid J
    Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.
    Bramlage CP; Kaps C; Ungethüm U; Bramlage P; Koziolek M; Wessels J; Krenn V; Pruss A; Müller GA; Strutz F; Burmester GR; Häupl T
    Scand J Rheumatol; 2008; 37(6):401-9. PubMed ID: 18830904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of rheumatoid arthritis: targeting cytokines.
    Zwerina J; Redlich K; Schett G; Smolen JS
    Ann N Y Acad Sci; 2005 Jun; 1051():716-29. PubMed ID: 16127012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytokines in rheumatoid arthritis: new therapeutic possibilities].
    Szekanecz Z; Szegedi G
    Orv Hetil; 1998 Apr; 139(14):819-23. PubMed ID: 9569729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine production in the rheumatoid joint: implications for treatment.
    Feldmann M; Brennan FM; Chantry D; Haworth C; Turner M; Abney E; Buchan G; Barrett K; Barkley D; Chu A
    Ann Rheum Dis; 1990 Jun; 49 Suppl 1():480-6. PubMed ID: 2197999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes.
    Xu H; He Y; Yang X; Liang L; Zhan Z; Ye Y; Yang X; Lian F; Sun L
    Rheumatology (Oxford); 2007 Jun; 46(6):920-6. PubMed ID: 17314215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging therapeutics for rheumatoid arthritis.
    Bingham CO
    Bull NYU Hosp Jt Dis; 2008; 66(3):210-5. PubMed ID: 18937634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.